Enoxaparin - NDC Database (Page 7)

175 records found
Page:First PagePrevious Page7Next PageLast Page
63323-655 May 01, 2019
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
68001-457 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-458 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-459 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-460 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-461 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-462 Oct 19, 2020
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-463 Oct 19, 2020
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-464 Oct 19, 2020
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
68083-634 Jul 11, 2023
Enoxaparin Sodium 30 mg/.3ml Subcutaneous Injection by Gland Pharma Limited
68083-635 Jul 11, 2023
Enoxaparin Sodium 40 mg/.4ml Subcutaneous Injection by Gland Pharma Limited
68083-636 Jul 11, 2023
Enoxaparin Sodium 60 mg/.6ml Subcutaneous Injection by Gland Pharma Limited
68083-637 Jul 11, 2023
Enoxaparin Sodium 80 mg/.8ml Subcutaneous Injection by Gland Pharma Limited
68083-638 Jul 11, 2023
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Gland Pharma Limited
68083-639 Jul 11, 2023
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Gland Pharma Limited
68083-640 Jul 11, 2023
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Gland Pharma Limited
70710-1757 Apr 01, 2021
Enoxaparin Sodium 30 mg/.3ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
70710-1758 Apr 01, 2021
Enoxaparin Sodium 40 mg/.4ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
70710-1759 Apr 01, 2021
Enoxaparin Sodium 60 mg/.6ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
70710-1760 Apr 01, 2021
Enoxaparin Sodium 80 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
Page:First PagePrevious Page7Next PageLast Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.